SSA SSA depositions are found in sarcoid granulomas Undefined Undefined Uncertain + Undefined Elevated serum SSA levels are found in patients with more active disease, severe lung function impairment, and need for systemic therapy. CXCL9 and CXCL10 Stimulation of T cell migration to sites of infl...
Non-pharmacological options are the implantation of a pacemaker, an implantable cardioverter-defibrillator (ICD) and catheter ablation. Due to the low body of evidence, diagnostic and therapeutic procedures must be adapted to the individual patient situation.Skowasch, D....
Mortality data from 1999 to 2016 were provided by the National Vital Statistics System (NVSS) with sarcoidosis (ICD-D86.X) as the underlying cause of death from all resident death certificates filed in the 50 states and the District of Columbia (DC). Data were analyzed using CDC WONDER, a...
Methods An institutional review board-approved, cross sectional, retrospective chart review was conducted at the Johns Hopkins Medical Institutions (JHMI). We reviewed the electronic medical records of patients with the International Classification of Diseases, Ninth Revision (ICD-9) diagnostic code for ...
Raheel AhmedRoyal Brompton Hosp, Newcastle upon TyneAzeem HassanNottinghamAli HasanHasan AhmadLeedsJoseph OkaforNational Heart and Lung Institute, LondonCaleb CarverNewcastleAyesha JadoonKhadija AmanullahTinley Park, ILLippincott Williams & WilkinsCirculation...
(active inflammation on nuclear imaging or LGE on CMR imaging with the exclusion of other possible causes) in whom clinically isolated CS was suspected, a diagnosis of sarcoidosis was made in 58% of patients who underwent lung or LN biopsy irrespective of the degree of lung involvement on ...
Background and Objectives: Sarcoidosis, marked by chronic inflammation and granuloma formation, shows a variable clinical course. While many patients have benign outcomes, others face chronic, life-threatening complications. Mortality studies in sarcoido
(1) Background: We aimed to analyze temporal trends in hospitalization and in-hospital mortality (IHM) in patients with sarcoidosis in Spain from 2001–2020. (2) Methods: Using the Spanish National Hospital Discharge Database, we included patients (aged